Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0680
0.00 (0.00%)
Apr 2, 2026, 3:08 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 41.41 million as of April 7, 2026. Its market cap has decreased by -51.34% in one year.
Market Cap
41.41M
Enterprise Value
32.68M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 41.41M, a decrease of -56.88%. That is a compound annual growth rate of -18.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 41.41M | -10.53% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 837.78M |
| Australian Clinical Labs | 380.63M |
| Healius | 377.59M |
| Monash IVF Group | 257.16M |
| Rhythm Biosciences | 63.29M |
| Cryosite | 53.45M |
| INOVIQ | 48.57M |
| BCAL Diagnostics | 36.50M |